SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-078736
Filing Date
2024-09-16
Accepted
2024-09-16 08:05:08
Documents
19
Period of Report
2024-09-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0214607-8k_kyverna.htm   iXBRL 8-K 60263
2 EMPLOYMENT OFFER LETTER, DATED SEPTEMBER 14, 2024, BETWEEN KYVERNA THERAPEUTICS, ea021460701ex10-1_kyverna.htm EX-10.1 94612
3 SEPARATION AND GENERAL RELEASE AGREEMENT, DATED SEPTEMBER 13, 2024, BETWEEN KYVE ea021460701ex10-2_kyverna.htm EX-10.2 48097
4 KYVERNA THERAPEUTICS, INC. 2024 INDUCEMENT EQUITY INCENTIVE PLAN ea021460701ex10-3_kyverna.htm EX-10.3 149395
5 PRESS RELEASE, DATED SEPTEMBER 16, 2024 ea021460701ex99-1_kyverna.htm EX-99.1 16116
6 GRAPHIC ex10-1_001.jpg GRAPHIC 3131
7 GRAPHIC ex10-2_001.jpg GRAPHIC 7889
  Complete submission text file 0001213900-24-078736.txt   644219

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE kytx-20240913.xsd EX-101.SCH 3018
9 XBRL LABEL FILE kytx-20240913_lab.xml EX-101.LAB 34240
10 XBRL PRESENTATION FILE kytx-20240913_pre.xml EX-101.PRE 22361
21 EXTRACTED XBRL INSTANCE DOCUMENT ea0214607-8k_kyverna_htm.xml XML 3689
Mailing Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608
Business Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608 5106268331
Kyverna Therapeutics, Inc. (Filer) CIK: 0001994702 (see all company filings)

IRS No.: 831365441 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41947 | Film No.: 241299377
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)